Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan versus standard of care in children with pulmonary arterial hypertension
2016-001062-28Phase 3Active
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of macitentan in pulmonary arterial hypertension (PAH), sponsored by Actelion Pharmaceuticals Ltd. Started Dec 2016; status: active.
02
Drugs
macitentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2016-001062-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001062-28.